RANA ATIQUE ANWER, SAJID GHAFOR, HUMA AHMAD. Neoadjuvant Docetaxel Plus Carboplatin Versus Epirubicin Plus Cyclophosphamide Followed by Docetaxel in Triple-Negative, Early-Stage Breast Cancer. Pakistan Journal of Medical & Health Sciences, [S. l.], v. 16, n. 08, p. 356, 2022. DOI: 10.53350/pjmhs22168356. Disponível em: https://pjmhsonline.com/index.php/pjmhs/article/view/2384. Acesso em: 21 nov. 2024.